Navigation Links
IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer
Date:9/13/2011

NEW YORK, Sept. 13, 2011 /PRNewswire/ -- IMMUNE Pharmaceuticals, an emerging leader in the development of Antibody based Therapeutics for the treatment of inflammatory diseases and cancer, today announced the appointment of Dr. Alan Harris, M.D., Ph.D., to the position of Chief Medical Officer.  In this new position, Dr. Harris will play a pivotal  role in the development of Bertilimumab, IMMUNE's phase II ready fully human monoclonal antibody in development for Crohn's Disease and Ulcerative Colitis,  as well as  NanoMAb development candidates in oncology. NanoMAbs are next generation bio- therapeutics with targeting mAbs conjugated to drug loaded nanoparticules.

"Alan brings impressive credentials and pharmaceutical clinical  development experience to the IMMUNE team," said Dr. Daniel Teper, Founder, Chairman of the Board and Chief Executive Officer of IMMUNE Pharmaceuticals.  "We are delighted to attract someone of Alan's caliber to our growing organization.  He will be a tremendous asset and play a critical role as IMMUNE evolves into a clinical stage company."

Dr. Harris led the clinical development of Novartis' somatostatin analogue, octreotide (Sandostatin®), for the treatment of gastrointestinal tumors and endocrine diseases.  More than 20 years after its introduction, Sandostatin remains a leading therapy, with sales reaching $1.4 billion in 2010.  Dr. Harris has also held leadership positions overseeing the clinical development of small molecules and biologics as Vice President of Research at Schering Plough, Therapeutic Head of Endocrinology at Pfizer, Senior Vice President of R & D and Chief Medical Officer at NPS Pharmaceuticals.

Dr. Harris is currently Adjunct Professor in the Department of Pharmacology at NYU Medical Center in New York, and was previously Associate Professor of Medicine at UCLA Medical School and Director of the Division of Clinical Pharmacology
'/>"/>

SOURCE IMMUNE Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
3. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
4. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
6. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
7. Peptimmune Initiates Phase I Study With a Novel Peptide Copolymer for the Treatment of Multiple Sclerosis
8. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
9. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
10. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
11. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 25, 2014 Leading events organizer UBM ... for the seventh year to São Paulo, Brazil ... August 2014. The event will co-locate with Food Ingredients South ... comprehensive meeting point for the pharmaceutical industry.      ... for pharmaceutical sales are now exploring the South ...
(Date:7/25/2014)... -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today ... second quarter 2014 financial results before the NASDAQ Global ... same day, Arena will host a conference call and ... Time). The conference call may be ... for international callers. Please specify to the operator that ...
(Date:7/24/2014)... Calif. , July 24, 2014   AcelRx ... pharmaceutical company focused on the development and commercialization of ... pain, today confirmed the PDUFA date for Zalviso remains ... that a rumor circulated online stating the Food and ... 24, 2014 there has been no notification to the ...
Breaking Medicine Technology:CPhI South America 2014 Launches with Generics Showing Huge Growth 2CPhI South America 2014 Launches with Generics Showing Huge Growth 3CPhI South America 2014 Launches with Generics Showing Huge Growth 4Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2
(Date:7/25/2014)... Port Washington, NY (PRWEB) July 25, 2014 ... to protecting the rights of consumers comments on a ... the widow of a smoker $23.6 billion in punitive ... which manufactures Kool brand cigarettes. The case is Cynthia ... in 2008 in the Florida First Circuit Court, Escambia ...
(Date:7/25/2014)... July 25, 2014 Hastings and ... discount attorney’s fees with regard to personal injury claims, ... a wide range of legal services for those that ... of another individual or corporation. Free initial consultation services ... validity of a potential personal injury claim . ...
(Date:7/25/2014)... July 25, 2014 (HealthDay News) -- Babies seem to ... By the time women are 34 weeks pregnant, ... their mother,s voice reciting a familiar nursery rhyme, the ... source of sensory stimulation in the developing fetus," Charlene ... of Florida,s College of Nursing, said in a university ...
(Date:7/25/2014)... of Anesthesiologists (ASA) today announced the launch of ... a national initiative designed to improve the patient ... than 40 leading health care organizations from across ... will convene for the first time at the ... Schaumburg, Ill. , The PSH collaborative participants will ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 CarePoint Health ... Dr. Edward Boylan, has joined our network, CarePoint Health ... community. Hundreds of highly skilled and experienced physicians comprise ... doctors and practices in Hudson County, representing a wide ... commitment to provide the highest quality care to patients ...
Breaking Medicine News(10 mins):Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:Hastings and Hastings Announces Complimentary Consultation Services 2Health News:Hastings and Hastings Announces Complimentary Consultation Services 3Health News:Rhymes Reveal Evidence of Learning in the Womb 2Health News:ASA launches national Perioperative Surgical Home learning collaborative 2Health News:ASA launches national Perioperative Surgical Home learning collaborative 3Health News:Dr. Boylan Joins CarePoint Health Medical Group 2
... Distance to care not a factor, study finds, urging greater ... News) -- Living farther away from transplant centers doesn,t explain ... apt than whites to be placed on the kidney transplant ... team that analyzed data on end-stage renal (kidney) disease patients ...
... start-ups, without forcing doctors into ... ... Corporation,today announced the pre-release of Praxis Electronic Medical Records,Version 4, featuring ... tap into the knowledge of other clinicians,enabling rapid start- ups for ...
... Nov. 9 Innovation Management Group,Inc. (IMG) announced ... 1.50, a,low cost, full screen magnification software. Most ... individuals who have extreme visual,impairments or are legally ... hundred to,several thousand dollars. The Magnifier is the ...
... at Military Bases and for Download -, PHOENIX, ... members, their families and veterans will be available,beginning Nov. ... Fighting, America Supports You, TriWest Healthcare Alliance and,many other ... "For the Troops" at 4 p.m. on,Nov. 16 at ...
... Genome Sciences,Inc. (Nasdaq: HGSI ) announced today that ... be webcast and may be accessed at, http://www.hgsi.com ... of Human Genome Sciences, senior management team will present,an ... at 4:30 pm Eastern,Time. Investors interested in listening ...
... genes associated with the Alzheimer,s ... FRESNO, Calif., Nov. 9 Consuming grapes may ... presented,this week at the Society for Neuroscience conference in ... in grapes, which,includes resveratrol, quercetin, catechins and other phytonutrients, ...
Cached Medicine News:Health News:Blacks in Poor Areas Less Likely to Be On Kidney Transplant Lists 2Health News:Infor-Med, Inc. Announces New Praxis EMR Version 4 with The Praxis Knowledge Exchanger(R) 2Health News:IMG Announces an Affordable Full Screen Software Magnifier for Home and Business Users 2Health News:TriWest, Grammy-Nominated Artist and Partners Release 'For the Troops' CD in Appreciation of Military Members 2Health News:TriWest, Grammy-Nominated Artist and Partners Release 'For the Troops' CD in Appreciation of Military Members 3Health News:Eating Grapes May Protect Against Alzheimer's Disease 2
... The Clariflex® Intraocular Lens is indicated ... years of age or older in whom ... IOL is a third-generation IOL design made ... is designed both to reduce internal reflections ...
... Chamber Lenses: The Bausch & Lomb PMMA Posterior ... for primary implantation for the visual correction of ... older where a cataractous lens has been removed ... to be placed in the ciliary sulcus or ...
... All USIOL lenses are manufactured ... and processes. Perspex CQ UV ... the multi-piece and single piece ... available in both nonphaco and ...
... sterile nonpyrogenic, transparent viscoelastic solution of highly ... mg/ml of high molecular weight (greater than ... physiological saline. In the limit of zero ... (105 Pa s) at 25 C and ...
Medicine Products: